Avenir Wellness Solutions (CURR) Stock Price, News & Analysis

Company Overview

Avenir Wellness Solutions, Inc., through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. It provides its products in beauty, health and wellness, and pet care categories under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. The company sells its products through drug and grocery chains, convenience stores, and mass retailers. It also offers its products under private label to retailers and multi-level marketers, as well as DTC, via online website orders. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in October 2022. Avenir Wellness Solutions, Inc. was founded in 2011 and is headquartered in Sherman Oaks, California.

Key Stats

• Today's Range: $2.75 to $3.30
• 50-Day Range: $0.11 to $4.35
• 52-Week Range: $2.17 to $13.59
• Volume: 18,142 shs
• Average Volume: 30,068 shs
• Market Capitalization: $31.21 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CURR Stock Analysis - Frequently Asked Questions

How have CURR shares performed this year?

Avenir Wellness Solutions' stock was trading at $0.11 at the beginning of 2024. Since then, CURR stock has increased by 2,581.8% and is now trading at $2.95.
View the best growth stocks for 2024 here.

How do I buy shares of Avenir Wellness Solutions?

Shares of CURR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 9/20/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Unclassified
• Industry: N/A
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CURR
• CUSIP: N/A
• CIK: 1643301
• Web: www.curepharmaceutical.com
• Phone: (805) 410-9962
• Fax: 805-487-7163
• Employees: 10
• Year Founded: 2011

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $52.49 million
• Price / Sales: 0.59
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 10,580,000
• Free Float: N/A
• Market Cap: $31.21 million
• Optionable: Not Optionable
• Beta: -0.05